Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/460
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Oxygen containing hetero ring > The hetero ring is six-membered > Chalcogen bonded directly to ring carbon of the hetero ring
Description: Subject matter wherein chalcogen is bonded directly to ring carbon of the hetero ring.










Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Patent Number Title Of Patent Date Issued
8679534 HMG-CoA reductase inhibitor extended release formulation Mar. 25, 2014
8673943 Fluorinated derivatives of deferiprone Mar. 18, 2014
8623912 Fostriecin derivatives and the pharmaceutical uses thereof Jan. 7, 2014
8603989 Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same Dec. 10, 2013
8592439 Long-term treatment of symptomatic heart failure Nov. 26, 2013
8591935 Methods and compositions for treating pain comprising a statin Nov. 26, 2013
8569362 Polyketide molecules as anticancer agents Oct. 29, 2013
8557835 Statin-carboxyalkylether combinations Oct. 15, 2013
8536222 Addition compounds of guanidinoacetic acid Sep. 17, 2013
8529890 Composition for the administration of polymeric drugs Sep. 10, 2013
8505730 Compositions, kits and regimens for the treatment of skin, especially decolletage Aug. 13, 2013
8501698 Crystal structures of SGLT2 inhibitors and processes for preparing same Aug. 6, 2013
8501759 Use of fibrates Aug. 6, 2013
8486374 Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses Jul. 16, 2013
8481591 Polymeric topical compositions Jul. 9, 2013
8481570 1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities Jul. 9, 2013
8475840 Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof Jul. 2, 2013
8476314 Substance with sedative effect Jul. 2, 2013
8476259 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension Jul. 2, 2013
8414958 Implant and method for the manufacture thereof Apr. 9, 2013
8394851 Osmoprotective complexes for prevention of mitochondrial free radical damage related skin aging Mar. 12, 2013
8383614 Hypercholestrolemia and tendinous injuries Feb. 26, 2013
8383651 Compounds which selectively modulate the CB2 receptor Feb. 26, 2013
8377918 Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents Feb. 19, 2013
8372889 Methods for modulating metabolism Feb. 12, 2013
8361972 Pharmaceutical formulations containing an SGLT2 inhibitor Jan. 29, 2013
8362086 Long acting injectable formulations Jan. 29, 2013
8349888 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury Jan. 8, 2013
8349889 Skin-care preparations containing mupirocin and betamethasone dipropionate Jan. 8, 2013
8343943 Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof Jan. 1, 2013
8338410 Neuroprotective compounds and pharmaceutical compositions comprising them Dec. 25, 2012
8318771 Method of treatment of nephrogenic diabetes insipidus Nov. 27, 2012
8278315 Radiotherapy method using x-rays Oct. 2, 2012
8278349 Cancer treatment using FTS and 2-deoxyglucose Oct. 2, 2012
8273791 Compositions, kits and regimens for the treatment of skin, especially decolletage Sep. 25, 2012
8263369 Compound ceramidastin, method for producing the same, and use of the same Sep. 11, 2012
8258125 HDL-boosting combination therapy complexes Sep. 4, 2012
8242167 Mannose derivatives for killing tumor cells Aug. 14, 2012
8221786 Pharmaceutical formulations containing an SGLT2 inhibitor Jul. 17, 2012
8222293 Treating learning deficits with inhibitors of Hmg CoA reductase Jul. 17, 2012
8211922 1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities Jul. 3, 2012
8207109 Food supplement with a slimming effect Jun. 26, 2012
8188144 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells May. 29, 2012
8183233 Stable pharmaceutical formulations May. 22, 2012
8173632 Process for the modification of the solid state of a compound and co-amorphous compositions produced with same May. 8, 2012
8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes May. 1, 2012
8158677 Treatment of viral infections by modulation of host cell metabolic pathways Apr. 17, 2012
8153685 Salts, addition compounds and complex compounds of guinadinoacetic acid Apr. 10, 2012
8138224 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof Mar. 20, 2012
8093288 Genipin derivatives and uses thereof Jan. 10, 2012

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16










 
 
  Recently Added Patents
Non-volatile semiconductor memory and data processing method in non-volatile semiconductor memory
Maize hybrid X08B748
Apparatus and method for noise removal by spectral smoothing
Dynamic allocation of access channels based on access channel occupancy in a cellular wireless communication system
Multi-function wrench for a power tool
Cylindrical LED fixture
People engine optimization
  Randomly Featured Patents
Valve stem travel limiting apparatus
Swing arm
Thermal ink jet defect tolerant resistor design
Pressure developing device
Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
Multi-channel echo compensation system
Brick
Insulin-like growth factor agonist molecules
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof
Geranium plant named Volcano